Efficacy and safety of doxycycline versus azithromycin for the treatment of Chlamydia trachomatis in cis-men: A systematic review and meta-analysis
International Journal of STD & AIDS · 2026-07 · 37 (8) · 823-832
DOI: 10.1177/09564624261435919 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift International Journal of STD & AIDS, online erschienen am 25.03.2026. Verfasst von Safa Boujemaa und 2 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biological Sciences, Biologica Training and Consulting, Tunis, Tunisia. Hauptthemen laut MEDLINE: Azithromycin, Doxycycline, Chlamydia trachomatis, Chlamydia Infections. Die Arbeit nennt 37 Literaturangaben.
Abstract (Originalsprache)
Introduction
Treatment for Chlamydia trachomatis include azithromycin and doxycycline; however, comparative studies in cis-male populations remain limited. This systematic review and meta-analysis assessed the efficacy and safety of azithromycin versus doxycycline for treating chlamydial infections among cis-men.
Methods
We searched PubMed/MEDLINE, Embase, Web of Science, Scopus, Cochrane Central Register of Controlled Trials, CINAHL, and Google Scholar. Randomized controlled trials comparing doxycycline (100 mg twice daily for 7 days) with azithromycin (1 g single dose) in cis-men infected with Chlamydia trachomatis were included. Risk of bias was assessed using the Cochrane RoB 2 tool and meta-analysis was reported in accordance with the PRISMA 2020 guidelines. The primary outcome was microbiological cure at last follow-up. Pooled effect estimates were calculated as odds ratios (ORs) with 95% confidence intervals (CIs) using the random-effects model. Subgroup, meta-regression, publication bias and sensitivity analyses were performed. The protocol was registered in PROSPERO (CRD42024535957).
Results
10 randomized controlled trials comprising 1172 cis-male participants were included. Overall, 560/602 (93%) participants treated with doxycycline and 504/627 (81%) treated with azithromycin achieved microbiological cure. Meta-analysis demonstrated significantly higher odds of cure with doxycycline compared with azithromycin (OR = 2.525, 95% CI = 1.329–4.796, p = 0.005). Adverse events were not significantly different between groups ( p = 0.757). Subgroup analysis showed significant superiority of doxycycline for rectal infection and chlamydia-associated nongonococcal urethritis ( p < 0.05), but not for prostate infection ( p = 0.745). Sensitivity analysis demonstrated strong reliability and no statistical evidence of publication bias ( p > 0.05).
Conclusions
Doxycycline demonstrated superior microbiological efficacy compared with azithromycin in cis-men with Chlamydia trachomatis . However, moderate heterogeneity was detected across studies and data for rectal and prostate infections were limited. Consequently, further well-designed trials are required to confirm these findings.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biological Sciences, Biologica Training and Consulting, Tunis, Tunisia.
- Department of Osteopathic Medicine, Lincoln Memorial University-DeBusk College of Osteopathic Medicine, Harrogate, TN, USA.
- Department of Biological Sciences, Bluefield University, Bluefield, VA, USA.
ORCID-Profile: Safa Boujemaa
Zitieren
APA
Boujemaa, S., Suri, G. S., & Kaur, G. (2026). Efficacy and safety of doxycycline versus azithromycin for the treatment of Chlamydia trachomatis in cis-men: A systematic review and meta-analysis. International Journal of STD & AIDS, 37(8), 823-832. https://doi.org/10.1177/09564624261435919
Vancouver
Boujemaa S, Suri GS, Kaur G. Efficacy and safety of doxycycline versus azithromycin for the treatment of Chlamydia trachomatis in cis-men: A systematic review and meta-analysis. International Journal of STD & AIDS. 2026;37(8):823-832. doi:10.1177/09564624261435919
BibTeX
@article{Boujemaa2026,
author = {Boujemaa, Safa and Suri, Gurparsad Singh and Kaur, Gurleen},
title = {Efficacy and safety of doxycycline versus azithromycin for the treatment of Chlamydia trachomatis in cis-men: A systematic review and meta-analysis},
journal = {International Journal of STD & AIDS},
year = {2026},
volume = {37},
number = {8},
pages = {823--832},
doi = {10.1177/09564624261435919}
}
EUVIMED